Nothing Special   »   [go: up one dir, main page]

Kuppe et al., 2017 - Google Patents

Investigations of glucocorticoid action in GN

Kuppe et al., 2017

View HTML
Document ID
10526559281010265639
Author
Kuppe C
Van Roeyen C
Leuchtle K
Kabgani N
Vogt M
Van Zandvoort M
Smeets B
Floege J
Gröne H
Moeller M
Publication year
Publication venue
Journal of the American Society of Nephrology

External Links

Snippet

For several decades, glucocorticoids have been used empirically to treat rapid progressive GN. It is commonly assumed that glucocorticoids act primarily by dampening the immune response, but the mechanisms remain incompletely understood. In this study, we inactivated …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids

Similar Documents

Publication Publication Date Title
Kuppe et al. Investigations of glucocorticoid action in GN
Tang et al. Activation of BNIP3-mediated mitophagy protects against renal ischemia–reperfusion injury
Lin et al. Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy
Kuwahara et al. Megalin-mediated tubuloglomerular alterations in high-fat diet–induced kidney disease
Assady et al. New insights into podocyte biology in glomerular health and disease
Maybin et al. Hypoxia and hypoxia inducible factor-1α are required for normal endometrial repair during menstruation
Souma et al. Erythropoietin synthesis in renal myofibroblasts is restored by activation of hypoxia signaling
Maeda et al. CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease
Higo et al. DNA single-strand break-induced DNA damage response causes heart failure
Madhusudhan et al. Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy
Leonhard et al. Scattered deletion of PKD1 in kidneys causes a cystic snowball effect and recapitulates polycystic kidney disease
Zschiedrich et al. Targeting mTOR signaling can prevent the progression of FSGS
Lin et al. A role of RIP3-mediated macrophage necrosis in atherosclerosis development
Xia et al. Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis
Athwal et al. SOX 9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis
Mitrofanova et al. Activation of stimulator of IFN genes (STING) causes proteinuria and contributes to glomerular diseases
Chen et al. Lipopolysaccharide induces chronic kidney injury and fibrosis through activation of mTOR signaling in macrophages
Thomasova et al. Murine double minute-2 prevents p53-overactivation-related cell death (podoptosis) of podocytes
Langworthy et al. NFATc1 identifies a population of proximal tubule cell progenitors
Liu et al. Activation of the intrinsic fibroinflammatory program in adult pancreatic acinar cells triggered by Hippo signaling disruption
Söderberg et al. Neutrophil extracellular traps in vasculitis, friend or foe?
Artelt et al. The role of palladin in podocytes
An et al. Interleukin-37 ameliorates coxsackievirus B3-induced viral myocarditis by modulating the Th17/regulatory T cell immune response
Zhao et al. Resolvin D1 protects lipopolysaccharide-induced acute kidney injury by down-regulating nuclear factor-kappa B signal and inhibiting apoptosis
Barthet et al. Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver